Protalex Inc - Company & Market Research Reports

Protalex is a clinical-stage biopharmaceutical company focused on the development of drugs for treating autoimmune and inflammatory diseases including Rheumatoid Arthritis (RA) and Immune Thrombocytopenia (ITP). Protalex’s lead product, PRTX-100, is a formulation of a proprietary, highly purified form of Staphylococcal Protein A, which is an immunomodulatory protein produced by bacteria. The company was founded in 1999 and is based in Florham Park, New Jersey.

Rheumatoid Arthritis - Pipeline Review, H2 2017 - Product Thumbnail Image

Rheumatoid Arthritis - Pipeline Review, H2 2017

  • Drug Pipelines
  • 1051 Pages
From
Rheumatoid Arthritis - Pipeline Review, H1 2017 - Product Thumbnail Image

Rheumatoid Arthritis - Pipeline Review, H1 2017

  • Drug Pipelines
  • 1020 Pages
From
From
From
From
From
From
From
From
From
Myasthenia Gravis - Pipeline Review, H2 2018 - Product Thumbnail Image

Myasthenia Gravis - Pipeline Review, H2 2018

  • Drug Pipelines
  • 133 Pages
From
From
From
  • 18 Results (Page 1 of 1)
Loading Indicator
adroll